Francisco Javier Cañada Selected Research

3-dehydroquinate dehydratase

9/2006

Determination of the bound conformation of a competitive nanomolar inhibitor of mycobacterium tuberculosis type II dehydroquinase by NMR spectroscopy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco Javier Cañada Research Topics

Disease

2	Infections 01/2021 - 08/2020
1	Atypical Hemolytic Uremic Syndrome 01/2021
1	Neoplasms (Cancer) 01/2021
1	Inflammation (Inflammations) 08/2020
1	Breast Neoplasms (Breast Cancer) 05/2019
1	Sepsis (Septicemia) 01/2014
1	Tuberculosis (Tuberculoses) 09/2006

Drug/Important Bio-Agent (IBA)

2	LectinsIBA 01/2021 - 08/2020
2	Biological ProductsIBA 05/2019 - 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 01/2021
1	AntigensIBA 01/2021
1	Tn antigenIBA 01/2021
1	CalciumIBA 01/2021
1	CarbohydratesIBA 01/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	AcetylgalactosamineIBA 01/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 08/2020
1	Glycoproteins (Glycoprotein)IBA 08/2020
1	GlucosidesIBA 05/2019
1	vanillinIBA 05/2019
1	GlucosidasesIBA 05/2019
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 05/2019
1	GlycosidesIBA 05/2019
1	3-dehydroquinate dehydrataseIBA 09/2006